EFTR - eFFECTOR Therapeutics 10% owner SR One Capital Management discloses sale of 609163 shares
2023-11-30 13:03:20 ET
More on eFFECTOR Therapeutics
- eFFECTOR stock rises after FDA fast track status for breast cancer therapy
- Seeking Alpha’s Quant Rating on eFFECTOR Therapeutics
- Historical earnings data for eFFECTOR Therapeutics
- Financial information for eFFECTOR Therapeutics
For further details see:
eFFECTOR Therapeutics 10% owner SR One Capital Management discloses sale of 609,163 shares